NKX2-6
Basic information
Region (hg38): 8:23701740-23706756
Links
Phenotypes
GenCC
Source:
- conotruncal heart malformations (Moderate), mode of inheritance: AR
- conotruncal heart malformations (Limited), mode of inheritance: AR
- congenital heart disease (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Persistent truncus arteriosus; Conotruncal heart malformations | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular | 15649947 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NKX2-6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | 18 | ||||
missense | 48 | 53 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | |||||
Total | 0 | 3 | 53 | 21 | 12 |
Variants in NKX2-6
This is a list of pathogenic ClinVar variants found in the NKX2-6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-23702248-T-C | Benign (Sep 04, 2018) | |||
8-23702404-A-AG | Benign (Sep 06, 2018) | |||
8-23702462-T-C | Conotruncal heart malformations | Uncertain significance (Oct 20, 2022) | ||
8-23702479-G-T | NKX2-6-related disorder | Uncertain significance (Apr 29, 2023) | ||
8-23702490-G-A | Conotruncal heart malformations | Likely benign (Oct 22, 2017) | ||
8-23702531-C-A | Conotruncal heart malformations | Uncertain significance (Jul 10, 2023) | ||
8-23702556-A-G | Conotruncal heart malformations | Likely benign (Mar 20, 2023) | ||
8-23702571-G-C | Conotruncal heart malformations • NKX2-6-related disorder • not specified | Benign (Jan 31, 2024) | ||
8-23702577-G-A | Conotruncal heart malformations | Likely benign (Aug 28, 2023) | ||
8-23702586-G-A | Conotruncal heart malformations | Likely benign (Mar 17, 2023) | ||
8-23702586-G-C | Conotruncal heart malformations | Likely benign (Jul 31, 2020) | ||
8-23702612-C-T | Conotruncal heart malformations | Uncertain significance (Mar 01, 2022) | ||
8-23702659-G-T | Conotruncal heart malformations | Uncertain significance (Dec 19, 2021) | ||
8-23702664-G-A | Likely benign (May 08, 2018) | |||
8-23702671-G-A | Conotruncal heart malformations | Uncertain significance (Feb 07, 2018) | ||
8-23702684-G-A | Conotruncal heart malformations | Uncertain significance (Dec 30, 2019) | ||
8-23702687-CGGGGCCCAGGCAGGGCTTGCCATCGCGCACCA-C | Uncertain significance (Mar 01, 2022) | |||
8-23702708-C-A | Conotruncal heart malformations | Uncertain significance (Dec 30, 2019) | ||
8-23702713-C-T | Conotruncal heart malformations • NKX2-6-related disorder | Uncertain significance (Oct 03, 2023) | ||
8-23702725-G-C | Conotruncal heart malformations | Uncertain significance (Nov 20, 2023) | ||
8-23702732-C-A | Conotruncal heart malformations | Uncertain significance (Jan 01, 2020) | ||
8-23702737-C-T | Conotruncal heart malformations | Uncertain significance (Nov 14, 2019) | ||
8-23702743-G-A | Conotruncal heart malformations | Uncertain significance (Jan 26, 2024) | ||
8-23702764-A-G | Conotruncal heart malformations | Uncertain significance (Oct 27, 2022) | ||
8-23702768-C-T | Inborn genetic diseases | Uncertain significance (Jan 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NKX2-6 | protein_coding | protein_coding | ENST00000325017 | 2 | 4148 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0189 | 0.906 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.264 | 165 | 175 | 0.944 | 0.00000800 | 1846 |
Missense in Polyphen | 44 | 47.282 | 0.93058 | 503 | ||
Synonymous | 1.72 | 63 | 83.0 | 0.759 | 0.00000384 | 684 |
Loss of Function | 1.51 | 4 | 8.84 | 0.453 | 4.08e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional activator (PubMed:15649947). In conjunction with NKX2-5, may play a role in both pharyngeal and cardiac embryonic development. {ECO:0000250|UniProtKB:P43688, ECO:0000269|PubMed:15649947}.;
- Disease
- DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. {ECO:0000269|PubMed:15649947, ECO:0000269|PubMed:24421281, ECO:0000269|PubMed:25195019, ECO:0000269|PubMed:25380965}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.106
Haploinsufficiency Scores
- pHI
- 0.0568
- hipred
- N
- hipred_score
- 0.220
- ghis
- 0.465
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.490
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nkx2-6
- Phenotype
- respiratory system phenotype; embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- nkx2.7
- Affected structure
- ventricular myocardium
- Phenotype tag
- abnormal
- Phenotype quality
- shortened
Gene ontology
- Biological process
- positive regulation of cell population proliferation;hypothalamus development;cell differentiation;embryonic heart tube development;negative regulation of apoptotic process;tongue development;positive regulation of transcription by RNA polymerase II;digestive tract development;atrial cardiac muscle cell development;ventricular cardiac muscle cell development;pharyngeal system development;pericardium development
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding